Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001486 · ClinicalTrials.gov registry record
Genetic Study of Schizophrenia
A clinical trial of Schizophrenia and Schizoaffective Disorder, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 4,914
- Enrollment target
- 1
- Study location
NCT00001486 is a study of Schizophrenia and Schizoaffective Disorder that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 4,914 participants, above the 203-participant average among 315 other Schizophrenia trials with a reported enrollment target (2321% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00001486, a study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 4,914 participants
- Enrollment target
- 1
- Study location
Study Summary
This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function to better understand how to treat and prevent this illness.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,914 participants |
| Start Date | 1995-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001486
The ClinicalTrials.gov registry entry for NCT00001486 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,914 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 203-participant average among 315 other Schizophrenia trials with a reported enrollment target (2321% higher). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 0 interventions.
NCT00001486 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001486 about?
NCT00001486 is a clinical study titled "Genetic Study of Schizophrenia". This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function to better understand how to treat and prevent this illness.
What is the current status of trial NCT00001486?
This trial is currently completed. The enrollment target is 4,914 participants. The study started on 1995-07-15.
What conditions does trial NCT00001486 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
Who is sponsoring clinical trial NCT00001486?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001486 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Tolerability of MDMA in Schizophrenia
RECRUITING · Phase 1
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.